M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1
Pathology - Research and Practice · 2024-08 · 260 · 155458
DOI: 10.1016/j.prp.2024.155458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-08. Verfasst von Lifen Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, B7-H1 Antigen, Chemokine CXCL1, Macrophages. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: M2 macrophages are known to play a significant role in the progression of triple-negative breast cancer (TNBC) by creating an immunosuppressive microenvironment. The aim of this study is to investigate the impact of M2 macrophages on TNBC and their correlation with programmed death-ligand 1 (PD-L1) expression. METHODS: We employed a co-culture system to analyze the role of the mutual regulation of M2 macrophages and TNBC cells. Employing a multifaceted approach, including bioinformatics analysis, Western blotting, flow cytometry analysis, ELISA, qRT-PCR, lentivirus infection, mouse models, and IHC, we aimed to elucidate the influence and mechanism of M2 macrophages on PD-L1 expression. RESULTS: The results showed a substantial infiltration of M2 macrophages in TNBC tissue, which demonstrated a positive correlation with PD-L1 expression. CXCL1 exhibited abnormally high expression in M2 macrophages and enhanced the expression of PD-L1 in TNBC cells. Notably, silencing CXCL1 or its receptor CXCR2 inhibited M2 macrophages-induced expression of PD-L1. Mechanistically, CXCL1 derived from M2 macrophages binding to CXCR2 activated the PI3K/AKT/NF-κB signaling pathway, resulting in increased PD-L1 expression in TNBC. CONCLUSION: Broadly speaking, these results provide evidence for the immunosuppressive role of M2 macrophages and CXCL1 in TNBC cells, indicating their potential as therapeutic biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
- Department of Forensic Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
- School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China. Electronic address: fmmult@foxmail.com.
- Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Electronic address: zhaoxinhan@mail.xjtu.edu.cn.
- Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. Electronic address: lingxiaozhang@xjtufh.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, L., Gu, S., Wang, L., Zhao, L., Li, T., Zhao, X., & Zhang, L. (2024). M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1. Pathology - Research and Practice, 260, 155458. https://doi.org/10.1016/j.prp.2024.155458
Vancouver
Zhang L, Gu S, Wang L, Zhao L, Li T, Zhao X, et al. M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1. Pathology - Research and Practice. 2024;260:155458. doi:10.1016/j.prp.2024.155458
BibTeX
@article{Zhang2024,
author = {Zhang, Lifen and Gu, Shanzhi and Wang, Lu and Zhao, Lin and Li, Tian and Zhao, Xinhan and Zhang, Lingxiao},
title = {M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {260},
pages = {155458},
doi = {10.1016/j.prp.2024.155458}
}
EUVIMED